Previous Article | Next Article ![]()
Infection and Immunity, January 2000, p. 335-341, Vol. 68, No. 1
Division of Infectious
Diseases,1 Departments of
Pediatrics,2 Internal
Medicine,5 and Microbiology and
Immunology,4 and Children's Hospital at
Montefiore,3 Albert Einstein College of
Medicine, Bronx, New York 10461
Received 5 May 1999/Returned for modification 24 June 1999/Accepted 5 October 1999
Lipoarabinomannan (LAM) is a component of the mycobacterial surface
which has been associated with a variety of deleterious effects on
immune system function. Despite the importance of LAM to the
pathogenesis of mycobacterial infection, there is no information available on its fate in vivo. In this study, we determined the pharmacokinetics and tissue distribution of exogenously administered LAM in mice. For measurements of serum and tissue LAM concentrations, we developed an enzyme-linked immunosorbent assay which used monoclonal antibodies of different isotypes to capture and detect LAM at concentrations of
0019-9567/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Clearance and Organ Distribution of
Mycobacterium tuberculosis Lipoarabinomannan (LAM) in the
Presence and Absence of LAM-Binding Immunoglobulin M
0.4 µg/ml. Intravenous administration of LAM to
mice resulted in transient serum levels with organ deposition in the
spleen and in the liver. Immunohistochemical studies localized LAM to
the spleen marginal zone macrophages and, to a lesser degree, to liver
macrophages. When LAM was administered to mice previously given a
LAM-binding immunoglobulin M (IgM), LAM was very rapidly cleared from
circulation. In those mice, deposition of LAM in the spleen was
significantly reduced while LAM deposition in the liver increased.
Administration of LAM-binding IgM resulted in significant levels of IgM
to LAM in bile consistent with an increased hepatobiliary excretion of
LAM in the presence of specific antibody. Bile, liver extracts, and
bile salts were found to rapidly inactivate the immunoreactivity of
LAM. The results indicate that serum clearance and organ deposition of
LAM in mice are affected by the presence of LAM-binding antibody and
suggest a mechanism by which antibody could modify the course of
mycobacterial infection.
*
Corresponding author. Mailing address: Albert Einstein
College of Medicine, Golding Building, Room 702, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-3768. Fax: (718) 430-8701. E-mail: afreedma{at}aecom.yu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»